Page last updated: 2024-08-26

bosentan anhydrous and DDD MPGNII

bosentan anhydrous has been researched along with DDD MPGNII in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Egido, J; Gómez-Garre, D; Gutierrez, S; Largo, R; Liu, XH; López-Armada, MJ; Palacios, I	1

Other Studies

1 other study(ies) available for bosentan anhydrous and DDD MPGNII

Article	Year
An orally active ETA/ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis. Kidney international, 1996, Volume: 50, Issue:3 Topics: Animals; Antibody Specificity; Blood Pressure; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Female; Glomerulonephritis, Membranoproliferative; Immunohistochemistry; In Situ Hybridization; Kidney; Kidney Function Tests; Protein Precursors; Proteinuria; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Endothelin; RNA, Messenger; Sulfonamides	1996

Article

Year

An orally active ETA/ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis.

Kidney international, 1996, Volume: 50, Issue:3

Topics: Animals; Antibody Specificity; Blood Pressure; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Female; Glomerulonephritis, Membranoproliferative; Immunohistochemistry; In Situ Hybridization; Kidney; Kidney Function Tests; Protein Precursors; Proteinuria; Rats; Rats, Wistar; Receptor, Endothelin A; Receptors, Endothelin; RNA, Messenger; Sulfonamides

1996